Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conestat alfa in hospitalized patients with COVID-19
NCT04414631Phase 2Terminated
- Sponsor
- University Hospital Basel
- Start
- Aug 2020
- Primary completion
- Sep 2021
- Countries
- 3
01
Overview
A Phase 2 trial of conestat alfa in coronavirus disease 2019 (COVID-19), sponsored by University Hospital Basel. Started Aug 2020; status: terminated.
02
Drugs
conestat alfa
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04414631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04414631.